Provectus Biopharmaceuticals Announces Acceptance of PV-10 Poster Presentation at Society for Immunotherapy of Cancer (SITC) 2023 Annual Meeting
07 août 2023 07h00 HE
|
Provectus Biopharmaceuticals Inc.
KNOXVILLE, TN, Aug. 07, 2023 (GLOBE NEWSWIRE) -- Provectus (OTCQB: PVCT) today announced that preclinical data from ongoing research on investigational cancer immunotherapy PV-10 (rose bengal...
Generic Oncology Drugs Market Surpasses US$24.4 billion in 2022, Set to Grow at CAGR 6.5% through 2033 | Persistence Market Research
03 août 2023 11h32 HE
|
Persistence Market Research
New York, Aug. 03, 2023 (GLOBE NEWSWIRE) -- The global market for generic oncology drugs is estimated to be worth US$24.4 billion in 2022, with a 6.5% CAGR to reach US$49.9 billion by the end of...
Provectus Biopharmaceuticals Announces Acceptance of PV-10 Poster Presentations at Society for Melanoma Research (SMR) 2023 Congress
01 août 2023 07h00 HE
|
Provectus Biopharmaceuticals Inc.
KNOXVILLE, TN, Aug. 01, 2023 (GLOBE NEWSWIRE) -- Provectus (OTCQB: PVCT) today announced that data from ongoing clinical trials of investigational cancer immunotherapy PV-10 (rose bengal sodium) for...
Europe Active Pharmaceutical Ingredients Market Set for Robust Growth Driven by Rising Biologics Adoption, Patent Expirations and Outsourcing Trends
31 juil. 2023 05h58 HE
|
Research and Markets
Dublin, July 31, 2023 (GLOBE NEWSWIRE) -- The "Europe Active Pharmaceutical Ingredients Market 2022-2032" report has been added to ResearchAndMarkets.com's offering. The report presents an...
Nanoparticles in Biotechnology, Drug Development and Drug Delivery Systems Research Report 2023
04 juil. 2023 04h28 HE
|
Research and Markets
Dublin, July 04, 2023 (GLOBE NEWSWIRE) -- The "Nanoparticles in Biotechnology, Drug Development and Drug Delivery Systems" report has been added to ResearchAndMarkets.com's offering. The scope of...
Provectus Biopharmaceuticals Establishes Research Collaboration with University of Tennessee College of Veterinary Medicine to Investigate Pharmaceutical-Grade Small Molecule Immunotherapy Rose Bengal Sodium for Canine Soft Tissue Sarcomas
28 juin 2023 07h00 HE
|
Provectus Biopharmaceuticals Inc.
KNOXVILLE, TN, June 28, 2023 (GLOBE NEWSWIRE) -- Provectus (OTCQB: PVCT) today announced that the Company has initiated a new sponsored research program with the University of Tennessee College of...
Provectus Biopharmaceuticals Announces Stockholder Approval to Undertake Reverse Split of Outstanding Equities and Reduce Number of Authorized Equities by Same Ratio
26 juin 2023 07h00 HE
|
Provectus Biopharmaceuticals Inc.
KNOXVILLE, TN, June 26, 2023 (GLOBE NEWSWIRE) -- Provectus (OTCQB: PVCT) today announced that the Company’s shareholders have approved the proposals of Provectus’s Board of Directors (Board) to seek...
Global Drug Discovery Outsourcing Market to 2030: Players Include Merck & Co, Thermos Fisher Scientific, Dalton Pharma Services and Oncodesign
20 juin 2023 06h33 HE
|
Research and Markets
Dublin, June 20, 2023 (GLOBE NEWSWIRE) -- The "Drug Discovery Outsourcing Market Size, Share & Trends Analysis Report 2023 - 2030" report has been added to ResearchAndMarkets.com's offering.The...
invIOs presents exciting preclinical data showing that immune-activating small molecule INV501 induces strong cytotoxic activity against solid tumors
19 juin 2023 08h30 HE
|
invIOs GmbH
INV501, a potentially first-in-class compound, induces strong anti-tumor immune responses in preclinical models in different solid tumor indicationsTreatment with INV501 significantly inhibits tumor...
Constrained Peptide Drugs Global Market 2023: Sector is Expected to Reach $17.28 Billion by 2030 at a CAGR of 38.94%
09 juin 2023 09h03 HE
|
Research and Markets
Dublin, June 09, 2023 (GLOBE NEWSWIRE) -- The "Constrained Peptide Drugs Market - A Global and Regional Analysis: Focus on Peptide Type, Product, and Region-Wise Analysis - Analysis and Forecast,...